Latest News and Press Releases

Largest real-world RECELL study shows 6.2-day shorter hospital stays and $300 million in savings, presented at BBA 2025.

AVITA Medical announces the first clinical publication of Cohealyx, demonstrating significantly faster wound bed vascularization and autograft readiness.

AVITA Medical's RECELL was recognized as the “Best New Technology Solution – Surgical” in the 2025 MedTech Breakthrough Awards.

Today: AVITA Medical’s Acute Wound Care Showcase 2025—clinical insights, patient stories, and transformative solutions in acute traumatic wound care.

AVITA Medical reported financial results for the first quarter 2025.

AVITA Medical to host Acute Wound Care Showcase 2025 via webcast on May 13, with leadership insights, product highlights, and clinical outcomes.

AVITA Medical will announce Q1 2025 financial results on May 8, 2025, followed by a conference call and webcast at 1:30 p.m. PT.

AVITA Medical announced that 16 abstracts will be presented at ABA 2025, featuring real-world and clinical data on RECELL, Cohealyx, and PermeaDerm.

AVITA Medical announces U.S. launch of Cohealyx™, a collagen-based dermal matrix designed to promote tissue integration and revascularization.

AVITA Medical announces new manufacturing agreement and amended distribution agreement with Stedical Scientific to further commercialization of PermeaDerm.